Leading specialty drug manufacturer to advance compliance,
oversight, and inspection readiness with Veeva Vault QualityDocs
and Veeva Vault Training
BARCELONA, Spain, July 25, 2024 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced that Neuraxpharm will use Veeva
Vault QualityDocs and Veeva Vault Training to
advance its quality operations. Veeva quality applications
will help Neuraxpharm achieve greater oversight and inspection
readiness, while improving collaboration across its network of over
100 contract development and manufacturing organizations
(CDMOs).
"Veeva Vault Quality enables Neuraxpharm to bring GxP
documentation and quality training onto one platform making quality
operations more efficient and scalable," said Susanne Cater, head of corporate quality at
Neuraxpharm. "With Veeva Vault QualityDocs and Veeva Vault
Training, we can advance quality document management and
compliance, including how we work with CDMOs."
Neuraxpharm is a pharmaceutical leader in disorders affecting
the central nervous system (CNS). Vault QualityDocs supports
efficient GxP content management and information sharing across its
sites, while Vault Training enables Neuraxpharm to deploy training
and curricula to help ensure GxP compliance.
"With Veeva Vault Quality, Neuraxpharm can streamline content
and training, enabling the company to scale as it expands its
product portfolio," said Sofia
Lange, director of quality strategy for Europe at Veeva. "We're excited to partner
with Neuraxpharm in advancing quality across its organization and
keep production of vital CNS treatments for patients on track."
Additional Information
For more on Veeva Vault
Quality, visit: veeva.com/eu/VaultQuality
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's
products and services and the expected results or benefits from use
of our products and services. These statements are based on our
current expectations. Actual results could differ materially from
those provided in this release and we have no obligation to update
such statements. There are numerous risks that have the potential
to negatively impact our results, including the risks and
uncertainties disclosed in our filing on Form 10-Q for the period
ended April 30, 2024, which you can
find here (a summary of risks which may impact our
business can be found on pages 35 and 36), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/veeva-vault-quality-helps-neuraxpharm-drive-seamless-quality-operations-and-collaboration-with-over-100-cdmos-302206099.html